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Background: β-Lactam compounds are the most widely used antibiotics.
They inactivate bacterial DD-transpeptidases, also called penicillin-binding
proteins (PBPs), involved in cell-wall biosynthesis. The most common bacterial
resistance mechanism against β-lactam compounds is the synthesis of
β-lactamases that hydrolyse β-lactam rings. These enzymes are believed to have
evolved from cell-wall DD-peptidases. Understanding the biochemical and
mechanistic features of the β-lactam targets is crucial because of the increasing
number of resistant bacteria. DAP is a D-aminopeptidase produced by
Ochrobactrum anthropi. It is inhibited by various β-lactam compounds and
shares ~25% sequence identity with the R61 DD-carboxypeptidase and the
class C β-lactamases.
Results: The crystal structure of DAP has been determined to 1.9 Å resolution
using the multiple isomorphous replacement (MIR) method. The enzyme folds
into three domains, A, B and C. Domain A, which contains conserved catalytic
residues, has the classical fold of serine β-lactamases, whereas domains B
and C are both antiparallel eight-stranded β barrels. A loop of domain C
protrudes into the substrate-binding site of the enzyme.
Conclusions: Comparison of the biochemical properties and the structure of
DAP with PBPs and serine β-lactamases shows that although the catalytic site
of the enzyme is very similar to that of β-lactamases, its substrate and inhibitor
specificity rests on residues of domain C. DAP is a new member of the family of
penicillin-recognizing proteins (PRPs) and, at the present time, its enzymatic
specificity is clearly unique.
Introduction
β-Lactam antibiotics kill bacteria by interfering specifi-
cally with the biosynthesis of peptidoglycans, the major
constituents of the bacterial cell wall. This polymer is
unique to bacteria and this explains the high specificity of
β-lactam compounds (Figure 1) and their relatively low
toxicity towards eukaryotic cells. The physiological targets
of β-lactam compounds are membrane-bound DD-pepti-
dases (usually called penicillin-binding proteins or PBPs)
that are responsible for the synthesis and remodelling of
the peptidoglycan. These peptidases are active-site serine
enzymes and perform their catalytic cycle according to an
acylation/deacylation mechanism. β-lactam antibiotics
acylate the active-site serine residue of the DD-peptidases,
forming rather stable covalent noncatalytic acyl enzymes [1].
One of the resistance mechanisms utilised by bacteria
against these compounds is the production of β-lactamases
that catalyse the irreversible hydrolysis of the amide bond
of the β-lactam ring, thus yielding inactive products [2].
Most β-lactamases are active-site serine enzymes and
follow a catalytic pathway similar to that of DD-peptidases.
Despite very low degrees of sequence identity, striking
structural similarities have been highlighted between serine
β-lactamases and DD-peptidases by comparing several
X-ray crystallographic structures of PBPs and class A and C
β-lactamases [3–14]. The structures of these enzymes can
be partly superimposed, most strikingly at the level of the
active centres [4]. They all exhibit a single domain contain-
ing two regions, one α/β and one all-helical, with the cat-
alytic site lying between them. In the immediate vicinity
of the active-site serine residue of DD-peptidases and β-lac-
tamases, three elements, conserved in all active-site serine
penicillin-recognizing enzymes (PRPs, including the PBPs
which covalently bind β-lactams), have been identified
that appear to be directly or indirectly involved in the sub-
strate recognition and catalytic processes [14]. The first
element (Ser–X–X–Lys sequence, where X is any amino
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acid) contains the active serine and a lysine residue the
sidechain of which also points into the active site. The
proximity of the serine and lysine sidechains suggests the
probable involvement of the lysine sidechain amino group
in the catalytic process [15–17]. The second element forms
one side of the catalytic cavity and consists of Tyr–X–Asn
(e.g. β-lactamases of classes C and D, and some PBPs) or
Ser–X–Asn (e.g. β-lactamases of class A and most PBPs)
sequences. The third element forms the opposite wall of the
catalytic cavity. It is generally composed of a Lys–Thr–Gly
sequence, but lysine can be replaced by histidine or argi-
nine, and threonine by serine in a few cases. A positively
charged sidechain, followed by one bearing a hydroxyl
group and a subsequent glycine residue, appears to be con-
served universally. These three structural and functional
elements are also found in the sequences of PRPs of
unknown three-dimensional structure [4,17,18].
A new PRP, a D-aminopeptidase (DAP) has been purified
from Ochrobactrum anthropi [19]. This Gram-negative
bacterium is an emerging nosocomial pathogen that can be
responsible for meningitis or septicemia in immunocom-
promised patients [20,21] and that is very resistant to
many antibiotics, including β-lactam compounds [22].
O. anthropi is a highly proteolytic bacterial species that
extracts amino acid residues from peptides present in
the medium via a pool of peptidases. Its ability to hydrol-
yse peptides with a free N-terminal D-amino acid via
several D-aminopeptidases [19,23,24] has raised consider-
able interest.
DAP can be considered a PRP on the basis of its primary
structure and the fact that it is inhibited by β-lactam com-
pounds. It has been isolated from strain SCRC C1–38 and
displays strict D-stereospecificity towards low molecular
weight D-amino acid amides, D-alanine N-alkylamides and
peptides with a D-alanine at the N terminus [19,23,24].
DAP has a molecular weight of ~120,000 and is composed
of two identical subunits (Mr = 54,000). The correspond-
ing gene has been isolated from O. anthropi and its
nucleotide sequence determined [19]. The deduced
amino acid sequence of the enzyme shows that it shares
25% and 22% identity with the Streptomyces R61 DD-car-
boxypeptidase (R61) and the class C β-lactamase from
Escherichia coli, respectively [23], including the three con-
served elements described above. Site-directed mutagen-
esis experiments [23] show that residues Ser62 and Lys65
are essential for catalysis and that Cys61 is probably
involved in the substrate-binding step. 
The resolution of the structure of DAP will supply an
additional structure in the family of PRPs and should be
especially interesting when one considers the unique sub-
strate profile of this enzyme. Furthermore, the enzymes
specific for D-amino acids are poorly characterised, and the
study of D-aminopeptidases is of interest for enzymatic
stereoselective synthesis in organic chemistry. We present
here the structure of the D-aminopeptidase from O. anthropi
SRC C1–38, solved at 1.9 Å resolution, and its comparison
with the structures of R61 [11,12], the class A β-lactamase
from Bacillus licheniformis [13] and the class C β-lactamase
from Enterobacter clocae P99 [14]. The DAP structure
reveals the presence of a ‘serine-β-lactamase’ catalytic
domain and of two additional domains, one of which is
likely to be responsible for the specific substrate recogni-
tion and interaction with β-lactam compounds. 
Results and discussion
Analysis of the structure
DAP has a dimeric structure, each monomer having
dimensions of ~67 × 60 × 47 Å (Figure 2). The monomer
consists of three domains (Figures 2a,b). The N-terminal
catalytic domain (domain A, residues 3–331) folds into two
regions, one α/β and one helical region. The α/β region is
formed by residues 3–62 and 182–331 and consists of a
main five-stranded antiparallel β sheet flanked by three
helices. Two additional antiparallel β strands (S3–S4) lie
perpendicular to the main β sheet. The all-helical region
(residues 63–181) contains eight helices (Figures 2a,b).
The structure of this domain is analogous to that of R61
and serine β-lactamases, which is consistent with the
sequence alignment results [23] (Figure 3).
Two additional domains, B (residues 341–418) and C
(residues 422–520), complete the structure. They are both
constituted by eight antiparallel β strands organised in
β barrels. Domain B is connected to domain A by an
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Figure 1
Structures of β-lactam compounds. (a) The basic structure for
cephalosporins (R1 = –CO-R); for 7-aminocephalosporanic acid
(7-ACA) R1 and R2 = H. *Annotates the scissile peptide bond in theβ-lactam ring. (b) Basic structure for penicillins (R1 = –CO-R); in
6-aminopenicillinic acid (6-APA) R1 = H. (c) Structure of cefotaxime.
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Figure 2
Overall structure of DAP. Ribbon diagrams
showing (a) the DAP dimer and (b) the DAP
monomer. Domains A, B and C are coloured
blue, green and orange, respectively. The
γ and Ω loops are purple and red, respectively.
(c) Stereoview of the Cα trace of the DAP
monomer. The figures were produced using
the program MOLSCRIPT [44], Raster3D [45]
and TURBO–FRODO [42].
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Figure 3
Comparison of the folds of (a) the catalytic
domain of DAP, (b) the DD-carboxypeptidase
from Streptomyces sp. R61 [11], (c) the
class A β-lactamase from B. licheniformis
[13], and (d) the class C β-lactamase from
E. cloacae P99 [14]. β Strands and α helices
are blue and red, respectively. The Ω loop lies
at the lower centre of each molecule. The
figures were produced with the programs
MOLSCRIPT [44] and Raster3D [45].
eight-residue peptide (residues 332–340). This domain
forms five hydrogen bonds with domain A through loop
408–411, as well as three hydrogen bonds, hydrophobic
contacts and two salt bridges with domain C through loop
406–410 and residue 372, respectively. Domain C is
connected to domain B by a short link (residues 419–421).
In contrast, domain C makes close contacts with the
helical region of the catalytic domain. Helix H5 of the cat-
alytic domain protrudes into domain C making extensive
hydrophobic interactions with aromatic and aliphatic
sidechains that cover the cavity of the β barrel. Similarly,
the 476–486 loop of domain C, which will be named the
‘γ loop’ hereafter, lies between the helical and the α/β
regions of domain A, thus forming part of the wall of the
catalytic pocket (see below). Interactions between
domains A and C are mostly hydrophobic but two salt
bridges and 12 hydrogen bonds can also be identified.
Substrate/inhibitor recognition and binding
R61 and DAP catalyse the hydrolysis of a peptide bond
between two D-amino acids situated respectively at the
C- and N-terminal ends of a peptide substrate. They prob-
ably use similar catalytic mechanisms involving conserved
residues [23]; however, they each specifically recognise
and bind only one of the two charged ends of the peptide
substrate. The environment of the active site is expected
to provide positive charges in R61 and negative charges in
DAP, in order to bind negatively and positively charged
substrates, respectively.
The active site of R61 contains several basic groups [11]
and is fairly open to the solvent. An analysis of the
electrostatic potential surface in R61 reveals that the sub-
strate-binding site of the enzyme is positively charged
(Figure 4a). These charges are supposed to be responsible
for the specific recognition of the C terminus of the
peptide substrate by the enzyme and, in part, for its lack
of aminopeptidase activity. The Arg285 sidechain, situ-
ated in the vicinity of the catalytic site, is probably
responsible for the specific recognition of the substrate
carboxylate (Figure 4d), as it is the only positively charged
residue situated in a good position to do so. In the struc-
ture of DAP, this residue is replaced by Asn275 that is too
far away from the catalytic centre to participate in sub-
strate binding (Figure 4d). 
Compared to R61 (and β-lactamases of classes A and C),
the catalytic site of DAP is less accessible to the solvent
owing to the presence of the C-terminal domains of the
enzyme (Figure 4c). It is situated in the bottom of a
crevice located at the interface between domain C and the
helical and the α/β regions of domain A. In contrast to
those of R61 or of β-lactamases (usually positively
charged), the substrate-binding site of DAP contains only
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Figure 4
DAP substrate-binding site. (a) Electrostatic
potential surface of the R61
DD-carboxypeptidase; red and blue indicate
negative and positive electrostatic potentials,
respectively. The cleavage site is localised by
a black arrow. (b) Electrostatic potential
surface of DAP. (c) Section through the
electrostatic potential surface of DAP using
the same colour code as in (a). (d) Stereoview
of the superposition of the substrate-binding
sites of DAP (atoms coloured using standard
conventions for residues of domain A and red
for residues from domain C) and R61
DD-carboxypeptidase (blue). Labels indicate
DAP/R61 residues. The figures were
produced using the programs GRASP [43],
MOLSCRIPT [44] and Raster3D [45].
one charged residue (Figure 4c), Asp481, situated on the
other side of the cleavage site compared to Arg285 in R61.
It is well positioned to stabilise the positive charge of the
substrate (Figures 4b,c). Asp481 is situated on the domain
C γ loop and might be responsible for the specific recogni-
tion of the N terminus of the substrate. 
Enzymological studies have shown that the affinity of
DAP is higher for unsubstituted β-lactam compounds than
for those in which the amino group is blocked by acyl moi-
eties [23] (Figure 1). As discussed above, when compared
with R61, the additional domains in the DAP structure
considerably reduce the accessibility of the active site for
potential ligands (Figures 4a,c). The structures of covalent
complexes formed between R61 and two cephalosporins
(cephalothin and cefotaxime) (Figure 1c) reveal the
importance of three threonine residues (Thr116, Thr299
and Thr301) that are directly involved in the binding of
these β-lactam antibiotics [12,15]. In DAP, these residues
are replaced by Trp114, Gly288 and Ala290, respectively
(Figure 5a), thereby reducing the number of possible
interactions with these inhibitors. Moreover, the sidechains
of N-substituted β-lactams, as in cefotaxime, would create
short contacts with the γ loop. Accordingly, Asano et al.
[23] have shown that DAP is inhibited by 7-ACA and 6-
APA (Figures 1a,b) with Ki values of 0.1 mM and 0.3mM,
respectively. The active-site topology of DAP indicates
that such unsubstituted β-lactams can bind in the same
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Figure 5
DAP β-lactam-binding site. Superposition of
the residues involved in the β-lactam-binding
sites of DAP (atoms coloured using standard
conventions) and (a) R61 (cyan) complexed
with cefotaxime [14]. The 7-ACA group and
the acyl moiety of the inhibitor are orange and
green, respectively. The black dashes
represent the putative stabilisation of the amino
group of β-lactam compounds by the γ loop of
DAP. (b) Class A β-lactamase from
B. licheniformis (green) [14] and (c) class C
β-lactamase from E. cloacae P99 (orange)
[14]. Helix α2 and strand β3 of DAP are shown
in grey. In order to improve clarity, (a–c) are not
represented in exactly the same orientation.
The figures were produced using the programs
MOLSCRIPT [44] and Raster3D [45].
orientation as cephalothin and cefotaxime in R61 and that
their free amino group may be stabilized by interaction
with atoms Oδ1 and Oδ2 of Asp481 and the mainchain car-
bonyl group of Ala482, provided by the γ loop (Figure 5a).
Therefore, on the one hand, the presence of the γ loop in
the active site of DAP considerably limits the size of poten-
tial ligands and, on the other hand, it compensates for the
absence of the substrate-binding threonine residues in R61.
In most of the characterised class A β-lactamases, an argi-
nine residue is present at position 244 [17,25]. The
α carbon of this residue is situated on the β4 strand and its
long sidechain points in the direction of the cavity. Arg244
has been proposed to participate in the binding of the car-
boxylic acid group of β-lactams. This residue has no
evident counterpart in the class C β-lactamase and R61
structures. In DAP, however, Arg295 is in the same loca-
tion as Arg244 of class A β-lactamases (Figure 5b). The
backbone atoms, as well as the Cβ atoms of both residues,
are superimposed whereas the guanidinium group of
Arg295 is not oriented toward the active centre. However,
there is an empty space available to allow a rotation along
the Cβ–Cγ bond, thus placing it in a position equivalent to
that of Arg244 (Figure 5b). Another interesting feature of
Arg244 is its implication in the mechanism of β-lactamase
inactivation by suicide substrates (clavulanate and sulbac-
tam) [17]. Despite the presence of the arginine residue,
the inactivation of DAP by clavulanate and sulbactam is
several orders lower than for class A β-lactamases, resem-
bling more the values observed for class C enzymes. With
4 mM clavulanic acid, the rate constants are ~0.0018 s–1 for
kf and 0.0009 s–1 for kr, where kf and kr characterise the
rates of acylation and deacylation, respectively, assuming
that the transiently inactivated species is an acyl–enzyme
adduct. Typical kf values for class C enzymes range from
0.003 to 0.010 s–1 with 4 mM clavulanic acid [26]. By con-
trast, there was no detectable inactivation of the enzyme
after 16 h in the presence of 4 mM sulbactam. In competi-
tion experiments, the Ki for sulbactam is 6 mM, signifi-
cantly greater than the value obtained for 6-APA but
similar to that for benzylpenicillin [23].
Structural comparison with the active site of serine
β-lactamases and PBPs
The catalytic mechanism of serine β-lactamases and PBPs
has been analysed on the basis of the generally accepted
mechanism for active-site serine proteases. The active site
contains both an ‘oxyanion hole’, involved in the stabilisa-
tion of the tetrahedral intermediates, and a general base
which abstracts the proton from the serine hydroxyl group
(for a review see [18]). Important residues of the three
characteristic regions are conserved in the sequence of
DAP [23]. Structural alignments of DAP with the struc-
tures of the class A β-lactamase from B. licheniformis [13],
the class C β-lactamase from E. cloacae P99 [14], and R61
[11,12] reveal that these regions overlap (Figure 5). 
In serine β-lactamases and PBPs, the nature of the specific
residue that enhances the nucleophilicity of the active
serine hydroxyl group remains unclear. Different candi-
dates have been proposed for acting as the general base.
In class A β-lactamases, two distinct residues have been
shown to be important in the catalytic mechanism by both
crystallographic and mutagenesis studies [13,18,27–29].
Although it is generally agreed that Glu166 acts as the
general base in the deacylation step, the identity of the
general base in the acylation step remains controversial,
with both Glu166 and Lys73 being potential candidates
(see [17] for a detailed discussion). Nonetheless, it is quite
clear that Glu166 is an essential residue in the catalytic
mechanism of class A β-lactamases. It has no equivalent in
PBPs and class C β-lactamases. Rather, in R61 and in the
class C β-lactamase from E. cloacae, the lysine residue of
the first conserved element (SXXK) and the Tyr150 of the
second element (YXN) have respectively been proposed
to act as general base in both the acylation and deacylation
step, depending on their position and environment in the
catalytic site [18].
In the DAP structure, the corresponding residues Lys65
and Tyr153 are situated at 2.9 Å and 2.84 Å, respectively,
from the hydroxyl group of Ser62 (Figure 6a), and are
therefore in a good position to abstract a proton from the
catalytic serine. However, at neutral pH, these sidechains
are expected to be protonated and the environment
should thus decrease their pKa values by at least 4–5 pH
units to enable them to remain unprotonated around
neutral pH values. We observed three possible ways for
abstracting the proton of the active-site serine residue of
DAP. On the one hand, and as observed in the R61 struc-
ture where His298 has been proposed to activate the puta-
tive base Tyr150, a histidine residue (His287) in the DAP
active site is in a good position to interact with Tyr153
(Figure 6a). On the other hand, this tyrosine and the Nδ2
atom of Asn155, which are both hydrogen bonded to
Lys65, might contribute to lower the pKa of the latter.
The important role of the corresponding lysine residue in
the catalytic mechanisms of R61 and β-lactamases has
been highlighted by mutagenesis experiments. Alterna-
tively, although the DAP Ω loop has a conformation differ-
ent from that of class A β-lactamases (Figure 3), an acidic
residue (Asp225) is in a position equivalent to that of
Glu166 (Figure 5b). Its sidechain is not directed towards
the catalytic residues but the environment allows a rota-
tion around the Cα–Cβ bond. After such a rotation, the
Asp225 sidechain can be positioned similarly to that of
Glu166 in class A β-lactamases relative to the conserved
serine and lysine residues. Furthermore, a water molecule
present near the catalytic serine hydroxyl group, could
mediate the interaction between Asp225 and Ser62. 
In conclusion, the structural analysis of DAP reveals
several residues that are potentially able to act as a general
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base in the catalytic mechanism. Further investigation will
be necessary to ascertain their respective roles. 
The distances separating atoms common to the active
sites of β-lactamases A and C, and R61 have been
reviewed and compared [30]. Distances separating the
Oγ atom of the catalytic serine and atoms of the surround-
ing conserved residues are of importance for approaching
the catalytic mechanism as they help in identifying the
residues that might act as the general base. One of these,
called the F distance, which spans the oxyanion pocket,
distinguishes the class A enzymes from the others [4].
This distance is determined in part by the contact of the
β3 strand with the residue immediately upstream of the
reactive serine. Class C β-lactamases and PBPs usually
have either glycine or alanine at this position whereas
class A β-lactamases predominantly have sidechains
similar to, or larger than, that of alanine, such that a tilt is
created in the β3 strand. The increased F distance in
class A β-lactamases has been proposed to allow an opti-
mised interaction between the C6 β-acylamido group of a
β-lactam and the β3 strand, so as to favour binding of
β-lactams over DD-peptides [30]. In the structure of DAP
the residue preceding the catalytic serine is a cysteine
(Cys61) and this results in an increased F distance, as in
class A β-lactamases. The importance of the nature of this
sidechain in DAP, which is itself not in direct contact
with the substrate, was confirmed by mutagenesis studies.
However, despite this expanded F distance and a number
of similarities between the active sites of DAP and class A
β-lactamases, the former enzyme preferentially binds
DD-peptides. Therefore, the properties of DAP seem to
bring the above hypothesis into question, although it
should be remembered that the binding of substituted
penicillins and cephalosporins is in part restricted by the
presence of the γ loop of the C domain protruding into the
active site of DAP. 
As in DD-peptidases, the turnover of β-lactams by DAP is
not significant. There is, however, a major difference. In
the former, the turnover is due to the high stability of the
covalent acyl–enzyme adduct, which is often rather easily
formed. Although the interactions have not been studied
in detail, it seems that DAP is not, or very slowly (see the
case of clavulanic acid), acylated by β-lactams. In this
respect, it will be interesting to compare the structure of
DAP with that of a ‘penicillin-resistant’ PBP when the
latter becomes available.
The comparison of the topology and the catalytic geome-
try of domain A of DAP with that of a DD-carboxypepti-
dase and class C and A β-lactamases confirms the broad
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Figure 6
DAP catalytic site. (a) Detailed stereoview of
residues involved in the substrate binding
(coloured by atom type). The putative
interactions between atoms of these residues
(distances between 2.7 and 3.2 Å) are
represented by dashed lines. (b) The electron
density from the final 2Fo–Fc σA-weighted
map contoured at 1σ. The figures were
produced using the program TURBO–
FRODO [42]. 
anatomical similarities suggested by sequence compar-
isons. Compared to the latter, the different substrate- and
β-lactam-specificities in DAP are probably due to the
presence of the γ loop of domain C protruding into the
active site of the enzyme. In this aminopeptidase, domain A
provides the catalytic machinery whereas domain C confers
the specificity. Domain B probably maintains domain C in
a good position to interact with the catalytic domain.
Previous analysis of X-ray crystallographic structures indi-
cated that class A and class C β-lactamases may have
evolved from bacterial DD-transpeptidases (for reviews,
see [4,18]) but the mechanism of the loss of peptidase
activity during evolution remains unclear. A possible
mechanism has been proposed for class A β-lactamases
involving an increase in the tilt of strand β3 by steric
contact with the Ω loop [4]. The analysis and comparison
of amino acid sequences and known structures of class C
and class A β-lactamases led to the conclusion that these
enzymes evolved independently in parallel paths, rather
than sequentially along the same path [4]. 
Biological implications
The emergence of antibiotic-resistant pathogenic bacte-
ria raises a worrying clinical problem. It has been caused
by the intensive use of antibiotics, of which β-lactam
compounds are the most widely used. These act by inac-
tivating the bacterial DD-peptidases, also called penicillin-
binding proteins (PBPs), that are involved in the
synthesis of the bacterial cell wall. One of the strategies
developed by bacteria for escaping these lethal com-
pounds is the synthesis of β-lactamases that hydrolyse
the β-lactam ring, thereby avoiding further reaction with
the PBPs. β-Lactamases have been proposed to have
evolved from an ancestral PBP. The insight into this
evolution is of interest in understanding the mechanism
of bacterial resistance toward antibiotics.
A new PRP, namely D-aminopeptidase (DAP), has been
purified from Ochrobactrum anthropi, an emerging
nosocomial pathogen. DAP is specific toward peptides
with a free D-amino acid at the N terminus. The N-ter-
minal part of its sequence has been shown to share about
25% identity with the Streptomyces R61 DD-carboxypep-
tidase and the class C β-lactamases, and contains the
three motifs conserved in all serine β-lactamases.
We solved the structure of DAP at atomic resolution.
DAP folds into three domains: a catalytic domain
(domain A) that is highly homologous to serine β-lacta-
mases, and two C-terminal domains (domains B and C).
Our study reveals that a loop of domain C, which pro-
trudes into the catalytic site of the enzyme, is probably
responsible for both substrate- and inhibitor-specificity.
Furthermore, despite a low degree of sequence identity,
DAP shows high structural homology with both class A
and class C β-lactamases, notably in the catalytic, sub-
strate- and inhibitor-binding sites. Nonetheless, DAP is
not readily acylated by β-lactam compounds, an observa-
tion that can be explained by a poor positioning of the
β-lactam carbonyl group relative to the active-site serine
hydroxyl group.
Materials and methods
Expression and purification of DAP 
The gene encoding DAP has been cloned from O. anthropi SCRC
C1–38 and the protein produced in E. coli using the pUC18 expres-
sion system. After cell lysis, a first purification step was performed by
ammonium sulphate fractionation of the clarified extract. The 60–95%
saturation precipitate was redissolved in 10 mM potassium phosphate
buffer, pH 7, containing 0.1 mM EDTA and 1 mM dithiothreitol (DTT).
The solution was loaded onto a QSFF column to which a linear NaCl
gradient (0.2–0.4 M) was applied. The fractions containing DAP eluted
around 0.35 M NaCl and were concentrated and filtered through an
AcA-34 column (20–400 kDa MW range) using the same buffer sup-
plemented with 0.3 M NaCl. The fractions containing the pure protein
were pooled and dialysed against 50 mM Tris, pH 8.0, containing
10 mM DTT, 0.1 mM EDTA and 1 mM NaN3. 
Starting with 3 l of culture, ~45 mg of pure protein was obtained with a
purification yield of 55%. The protein was concentrated to 9 mg/ml by
dialysis against dry PEG 20,000, and stored at 4°C.
Crystallisation and preparation of heavy-atom derivatives 
Crystals of DAP were grown at 21°C using the hanging-drop vapour dif-
fusion method by mixing protein solution and precipitant solution in a 1:1
ratio. Crystals were grown using a protein concentration of 9mg/ml in
10 mM Tris pH 8, 10 mM DTT, 0.1 mM EDTA and 1 mM sodium azide.
The drops contained 2 µl of protein and 2 µl of reservoir solution that
contained 30% PEG 400 and 0.1 M sodium acetate, pH 5. Bipyramidal
crystals appeared within two days and were large enough for data col-
lection within a week, reaching a maximum length of 0.9 mm. 
Platinum and xenol heavy-atom derivatives were prepared by soaking
crystals at 21°C in a solution containing 30% PEG 400, 0.1 M sodium
acetate, pH 5, and 5 mM K2PtCl4, for 15 h, and by bathing crystals in
xenon [31] at a pressure of 10 bar.
Data collection
The crystals belong to space group P41212 with unit-cell parameters
a = b = 82.86 Å, c = 204.65 Å. The asymmetric unit contains one mol-
ecule and the solvent content is 61.4%.
The native and the xenon derivative data sets were collected at 4°C at
the LURE Orsay synchrotron outstation using a Mar-Research imaging
plate detector on beamline DW32 (λ = 0.97 Å) and D41A (λ = 1.375 Å),
respectively. The platinum derivative X-ray diffraction data set was col-
lected at room temperature on a MacScience DIP2030 image plate
system, using CuKα radiation. The latter was produced by a Nonius
FR591 rotating anode generator equipped with a double mirror X-ray
optical system and running at 100 mA, 45 kV. All the diffraction data
were auto-indexed, processed, scaled and merged using DENZO and
SCALEPACK from the HKL package [32] (Table 1).
Multiple isomorphous replacement phasing and map quality
improvement
The structure was solved by the multiple isomorphous replacement (MIR)
method using two heavy-atom derivatives (platinum and xenon [31]).
Heavy-atom positions were located by difference Patterson maps and
difference Fourier maps using the CCP4 package [33]. Heavy-atom posi-
tions, occupancies and isotropic B factors were refined with the program
SHARP [34] (Table 1). The initial MIR phases were extended to 1.9 Å
and the initial density map was improved by density modification using
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DM [33]. The electron-density map displayed clear molecular boundaries
but was otherwise uninterpretable. Bones were generated from this map
by the program MAPMAN [35] and were converted into a Brookhaven
format coordinate file. In order to improve map quality this file was used
as input for a refinement using the maximum-likelihood program REFMAC
[36] combined with ARP [37]. Figure 6b shows the refined 2Fo–Fc elec-
tron-density map (at 1σ) contoured around the active-site residues.
Model building and refinement
The WarpNtrace procedure of ARP [38] was used to attempt automatic
model tracing. We used the standard protocol [39] with the ‘big cycle’
being iterated six times. At the end, ARP was able to automatically build
483 of the 520 residues in seven different mainchain fragments. The
longest chain, close to the N terminus, contained 242 residues. All chains
were docked into the sequence and 296 sidechains were completely
built. At this stage, manual fitting into SIGMAA-weighted electron-density
maps [39] was initiated using TURBO-FRODO followed by maximum-
likelihood-based refinement cycles employing the program REFMAC [36].
ARP [37] was used to add water molecules automatically. Five percent of
the observations were set aside for cross-validation analysis [40] and a 2-
Gaussian bulk-solvent correction was applied. The final R factor and Rfree
are 16.3% and 19.2%, respectively, for all data within the 15–1.9 Å reso-
lution range. The results of the refinement are summarised in Table 1.
Calculations relating to model validation, model analysis and structural
alignment were carried out using PROCHECK [41] and TURBO-FRODO
[42]. Drawings were generated with the programs TURBO-FRODO [32],
GRASP [43], MOLSCRIPT [44] Raster3D [45] and CHEM DRAW [46].
Accession numbers
The coordinates and structure factors of DAP have been deposited in
the Protein Data Bank (entry code 1EI5).
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